Bacteriocins: antibiotics in the age of the microbiome
- 7 April 2017
- journal article
- review article
- Published by Portland Press Ltd. in Emerging Topics in Life Sciences
- Vol. 1 (1) , 55-63
Abstract
Antibiotics have revolutionised the treatment of infectious disease and improved the lives of billions of people worldwide over many decades. With the rise in antimicrobial resistance (AMR) and corresponding lack of antibiotic development, we find ourselves in dire need of alternative treatments. Bacteriocins are a class of bacterially produced, ribosomally synthesised, antimicrobial peptides that may be narrow or broad in their spectra of activity. Animal models have demonstrated the safety and efficacy of bacteriocins in treating a broad range of infections; however, one of the principal drawbacks has been their relatively narrow spectra when compared with small-molecule antibiotics. In an era where we are beginning to appreciate the role of the microbiota in human and animal health, the fact that bacteriocins cause much less collateral damage to the host microbiome makes them a highly desirable therapeutic. This review makes a case for the implementation of bacteriocins as therapeutic antimicrobials, either alone or in combination with existing antibiotics to alleviate the AMR crisis and to lessen the impact of antibiotics on the host microbiome.Keywords
This publication has 84 references indexed in Scilit:
- Persistence of the Oral Probiotic Streptococcus salivarius M18 Is Dose Dependent and Megaplasmid Transfer Can Augment Their Bacteriocin Production and Adhesion CharacteristicsPLOS ONE, 2013
- BAGEL3: automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptidesNucleic Acids Research, 2013
- Bacteriocin Production: a Probiotic Trait?Applied and Environmental Microbiology, 2012
- Mechanisms of Resistance to Bacteriocins Targeting the Mannose Phosphotransferase SystemApplied and Environmental Microbiology, 2011
- Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colonProceedings of the National Academy of Sciences, 2010
- In Vivo Activities of Recombinant Divercin V41 and Its Structural Variants against Listeria monocytogenesAntimicrobial Agents and Chemotherapy, 2010
- Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-ChallengeNew England Journal of Medicine, 2009
- Capacity of Human Nisin- and Pediocin-Producing Lactic Acid Bacteria To Reduce Intestinal Colonization by Vancomycin-Resistant EnterococciApplied and Environmental Microbiology, 2008
- Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118Proceedings of the National Academy of Sciences, 2007
- A Five-Strain Probiotic Combination Reduces Pathogen Shedding and Alleviates Disease Signs in Pigs Challenged with Salmonella enterica Serovar TyphimuriumApplied and Environmental Microbiology, 2007